Sarah Ford
Drug Restores Memory Function in Alzheimer’s Model
Building on earlier work funded by BrightFocus, researchers have discovered a promising new drug compound that reverses some
Alzheimer’s effects on memory in mice.Â
Four years ago, a research team led by BrightFocus grantee and Nobel Laureate Dr. Paul Greengard established the connection between increased striatal-enriched tyrosine phosphatase (STEP) levels and Alzheimer’s changes in mice, and showed that removing STEP had the effect of restoring synaptic connections.Â
Since their discovery of STEP, this research team has been searching for a drug that would block its damaging effects on brain synapses. They focused their efforts on finding a STEP inhibitor, studying thousands of small molecules in their quest.Â
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Corporate Volunteering: The Business Case for an Employee Volunteer Program
Corporate volunteering has evolved well beyond the occasional company service day. A well-designed employee volunteer program can strengthen employee engagement, reinforce company culture, develop leadership skills,…
Environmental Awareness Month
Every September, environmental organizations around the Nation come together in recognition of Environmental Awareness Month, with a goal to raise awareness about environmental issues that…
Join Feeding America and Take Action During Hunger Action Month
No one should have to go hungry in the richest country in the world — yet millions of Americans don’t have enough to eat. Our…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
